GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Caregen Co 214370.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

27,500

-2.31%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩72.81bn

FY2016FY2025

Net income

₩20.10bn

FY2016FY2025

Free cash flow

₩13.67bn

FY2016FY2025

Shareholders' equity

₩212.47bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩72.81bn₩82.59bn₩79.21bn₩69.10bn₩59.09bn₩60.30bn₩64.70bn₩51.21bn₩57.89bn₩46.84bn
Gross profit₩52.24bn₩55.32bn₩58.36bn₩52.35bn₩45.54bn₩48.64bn₩53.70bn₩32.85bn₩45.94bn₩38.70bn
Research and development₩5.76bn₩7.01bn₩5.82bn₩6.28bn₩5.03bn₩3.84bn——₩3.01bn₩3.21bn
Operating income₩20.40bn₩34.60bn₩40.38bn₩33.63bn₩28.27bn₩31.98bn₩35.15bn₩16.55bn₩31.58bn₩25.68bn
Net income₩20.10bn₩32.31bn₩39.93bn₩27.27bn₩25.32bn₩31.48bn₩28.07bn₩16.49bn₩24.29bn₩22.96bn
Diluted earnings per share411.26659.54812.67555.00516.393,210.142,819.381,623.842,372.842,165.64

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩231.27bn₩240.70bn₩247.28bn₩234.07bn₩226.76bn₩216.56bn₩231.85bn₩218.94bn₩247.02bn₩249.13bn
Cash and short-term investments—₩44.26bn₩132.72bn₩140.48bn₩136.27bn₩127.63bn₩167.40bn₩156.69bn₩147.71bn₩175.74bn
Total liabilities₩18.80bn₩17.72bn₩19.98bn₩18.09bn₩17.04bn₩11.40bn₩14.84bn₩14.18bn₩15.19bn₩15.02bn
Shareholders' equity₩212.47bn₩222.98bn₩227.30bn₩215.98bn₩209.72bn₩205.16bn₩217.01bn₩204.75bn₩231.83bn₩234.11bn
Shares outstanding49m49m49m49m49m10m10m10m10m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩18.59bn₩13.49bn₩28.60bn−₩27.68bn₩51.86bn₩30.78bn₩69.66bn−₩6.82bn₩47.88bn−₩15.94bn
Capital spending−₩4.92bn−₩66.97bn−₩9.70bn−₩3.03bn−₩3.89bn−₩21.08bn−₩6.16bn−₩2.28bn−₩5.57bn−₩4.32bn
Free cash flow₩13.67bn−₩53.49bn₩18.90bn−₩30.70bn₩47.97bn₩9.70bn₩63.50bn−₩9.10bn₩42.31bn−₩20.26bn
Dividends paid−₩31.13bn−₩31.45bn−₩28.50bn−₩24.51bn−₩20.59bn−₩34.74bn−₩34.74bn−₩12.28bn−₩16.42bn−₩6.43bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩18.79bn₩22.70bn₩16.31bn₩17.09bn₩18.12bn₩21.29bn₩21.36bn₩20.32bn
Gross profit₩12.83bn₩15.37bn₩10.39bn₩14.61bn₩12.59bn₩14.64bn₩11.94bn₩17.63bn
Operating income₩5.24bn₩10.21bn−₩7.07bn₩9.87bn₩7.44bn₩10.17bn₩6.13bn₩12.69bn
Net income₩4.30bn₩11.69bn−₩3.28bn₩10.16bn₩4.79bn₩8.43bn₩5.07bn₩11.70bn
Diluted earnings per share88.08239.30-67.15207.8098.11172.50103.68238.75
Cash from operations₩7.71bn₩9.06bn₩6.72bn₩2.64bn₩4.16bn₩5.06bn₩3.21bn₩2.21bn
Capital spending−₩650.0m−₩515.0m−₩1.08bn−₩2.46bn−₩905.0m−₩468.0m−₩320.0m−₩658.0m
Free cash flow₩7.06bn₩8.55bn₩5.64bn₩178.0m₩3.25bn₩4.59bn₩2.89bn₩1.55bn
Total assets₩241.26bn₩245.37bn₩231.27bn₩233.97bn₩233.98bn₩249.96bn₩240.70bn₩236.59bn
Cash and short-term investments—————₩49.22bn₩44.26bn₩42.89bn
Shareholders' equity₩218.66bn₩214.47bn₩212.47bn₩215.48bn₩216.88bn₩211.89bn₩222.98bn₩220.72bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin71.8%67.0%73.7%75.8%77.1%80.7%—
Operating margin28.0%41.9%51.0%48.7%47.8%53.0%—
Net margin27.6%39.1%50.4%39.5%42.8%52.2%—
Return on equity9.5%14.5%17.6%12.6%12.1%15.3%—
Return on assets8.7%13.4%16.1%11.6%11.2%14.5%—
Revenue growth-11.8%4.3%14.6%16.9%-2.0%-6.8%—
Earnings growth-37.8%-19.1%46.4%7.7%-19.6%12.1%—
Current ratio9.92x11.95x14.71x15.15x15.16x30.61x—
Debt to equity—0.00x0.00x0.00x0.00x0.00x0.00x
Equity ratio91.9%92.6%91.9%92.3%92.5%94.7%—
Interest coverage—————7200.59x—
R&D as a share of sales7.9%8.5%7.4%9.1%8.5%6.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.8%3.8%7.2%
Operating income-15.3%-8.6%-0.1%
Net income-9.7%-8.6%0.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.2%71.9%73.9%75.5%
Operating margin35.4%42.5%44.7%46.9%
Net margin33.7%39.4%41.7%42.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings174.643.733.849.425.84.55.48.77.27.6
Price to sales48.217.117.119.511.02.32.42.83.03.7

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 29 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2018
Paid in the year200.00437.001,040.00580.00500.00420.00700.00120.00
  • 5-for-1 split · 25 Aug 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.